Agreed. This is a game changer in my opinion. 2018 shaping up to...

Agreed.

This is a game changer in my opinion. 2018 shaping up to be a very big year for these guys. Few remaining CFDA and FDA approvals then the flood gates open. The capital gained from this placement will allow them to fulfill the backlog in orders and ramp up sales and distribution into the new year.

Who is Mr Steven Meng or Meng Xianhui, is a powerhouse in the China Pharma space. After some digging I found he is former executive director / deputy general manager of sales and marketing, and 7th largest equity holder, in Sihuan Pharma Holdings.

Before that he was the department head of a state owned enterprise for 10years so would have some valuable contacts high up. Source Bloomberg.

So he certainly has the reputation to match the bullish announcement. Very promising and yet to register on people's radar as they focus on the Christmas ham instead. His reach into china dist channels / Hospitals and government contacts given his positions at Sihuan has me calling this an inflection point in the company.

Best of luck

DYOR